TipRanks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
GANX
Gain Therapeutics
RESEARCH TOOLSreports
Want to see GANX full AI Analyst Report?

Gain Therapeutics (GANX) Income Statement

470 Followers

Gain Therapeutics Income Statement

Last quarter (Q2 2026), Gain Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Gain Therapeutics's net income was $-4.68M. See Gain Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 55.18K$ 140.11K$ 164.99K
Gross Profit
$ 0.00$ 0.00$ 55.18K$ 140.11K$ 164.99K
Operating Expenses
$ 18.71M$ 20.35M$ 22.31M$ 17.92M$ 13.99M
Depreciation and Amortization
$ 94.05K$ 84.07K$ 83.58K$ 64.17K$ 15.48K
EBITDA
$ -19.21M$ -19.79M$ -22.10M$ -17.43M$ -13.87M
Operating Income
$ -18.71M$ -20.35M$ -22.25M$ -17.78M$ -13.83M
Other Income/Expenses
$ -589.28K$ 476.22K$ 64.89K$ 279.28K$ -60.42K
Pretax Income
$ -19.30M$ -19.87M$ -22.19M$ -17.50M$ -13.89M
Net Income
$ -20.16M$ -20.41M$ -22.27M$ -17.59M$ -13.89M
Per Share Metrics
Basic EPS
$ -0.61$ -0.89$ -1.71$ -1.48$ -1.37
Diluted EPS
$ -0.61$ -0.89$ -1.71$ -1.48$ -1.37
Weighted Average Shares Outstanding
 32.97M 22.88M 13.01M 11.88M 10.17M
Weighted Average Shares Outstanding (Diluted)
 32.97M 22.88M 13.01M 11.88M 10.17M
Currency in USD

Gain Therapeutics Earnings and Revenue History